Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Latest News – 6 November 2025

Publication

Paul-Ehrlich-Institut Publishes Tissue Vigilance Report 2023

International Campaign

10 years of #MedSafetyWeek – We all have the power to make medicines safer

Press Releases

2025 Langen Science Award Winner: Dr Daniel Kirschenbaum Researches New Ways in Which Immune Cells Protect the Brain and Combat Cancer

Influenza Season 2025/2026

More Than 18 Million Doses of Influenza Vaccine Already Released for the 2025/2026 Flu Season

#VaccineFacts

#VaccineFacts Continue Their Impact: The Paul-Ehrlich-Institut Provides Vaccine Information – Even Beyond the Digital Awareness Campaign

Medicine Safety

Pharmacovigilance Report on the Use of COVID-19 Vaccines – Status as of 31 December 2024

FAQ: What should be taken into account when using public data on reports of suspected adverse events?

International Work

CHMP Meeting Highlights July 2025

PRAC Meeting Highlights September 2025

Information on the Topic of Vaccination Damages

The Paul-Ehrlich-Institut is not responsible for processing applications for recognition of vaccine damages.

The Paul-Ehrlich-Institut does not have any information, figures/data on vaccine damage procedures.

Recognition procedures for vaccination damages in accordance with section 24 of the Social Code (Sozialgesetzbuch, SGB) XIV are handled exclusively by the Social Welfare Office in the federal state in whose territory the vaccination was carried out. Sections 4, 5 and 113 of the SGB XIV provide information on the competent authority, compensation for official measures and payment obligations.

Important Short Links for Your Research

Updated: 06.11.2025

top